{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:19:29Z","timestamp":1787242769658,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"The Danish Rheumatism Association"},{"name":"The Faculty of Health at Aarhus University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13075-016-0964-7","type":"journal-article","created":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T07:19:06Z","timestamp":1458544746000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["The interleukin-20 receptor axis in early rheumatoid arthritis: novel links between disease-associated autoantibodies and radiographic progression"],"prefix":"10.1186","volume":"18","author":[{"given":"Tue Wenzel","family":"Kragstrup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stinne Ravn","family":"Greisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Aagaard","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Stengaard-Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merete Lund","family":"Hetland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"H\u00f8rslev-Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Junker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkel","family":"\u00d8stergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malene","family":"Hvid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Vorup-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Sokolove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bent","family":"Deleuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,11]]},"reference":[{"key":"964_CR1","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","volume":"376","author":"DL Scott","year":"2010","unstructured":"Scott DL, Wolfe F, Huizinga TWJ. Rheumatoid arthritis. Lancet. 2010;376:1094\u2013108.","journal-title":"Lancet."},{"key":"964_CR2","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.4049\/jimmunol.168.11.5397","volume":"168","author":"K Wolk","year":"2002","unstructured":"Wolk K, Kunz S, Asadullah K, Sabat R. Cutting edge: immune cells as sources and targets of the IL-10 family members? J Immunol. 2002;168:5397\u2013402.","journal-title":"J Immunol."},{"key":"964_CR3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.intimp.2004.01.007","volume":"4","author":"ML Nagalakshmi","year":"2004","unstructured":"Nagalakshmi ML, Murphy E, McClanahan T, de Waal MR. Expression patterns of IL-10 ligand and receptor gene families provide leads for biological characterization. Int Immunopharmacol. 2004;4:577\u201392.","journal-title":"Int Immunopharmacol."},{"key":"964_CR4","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nri3766","volume":"14","author":"S Rutz","year":"2014","unstructured":"Rutz S, Wang X, Ouyang W. The IL-20 subfamily of cytokines\u2014from host defence to tissue homeostasis. Nat Rev Immunol. 2014;14:783\u201395.","journal-title":"Nat Rev Immunol."},{"key":"964_CR5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1517\/14728222.2011.534461","volume":"15","author":"R-X Leng","year":"2011","unstructured":"Leng R-X, Pan H-F, Tao J-H, Ye D-Q. IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases. Expert Opin Ther Targets. 2011;15:119\u201326.","journal-title":"Expert Opin Ther Targets."},{"key":"964_CR6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrd4176","volume":"13","author":"R Sabat","year":"2014","unstructured":"Sabat R, Ouyang W, Wolk K. Therapeutic opportunities of the IL-22-IL-22R1 system. Nat Rev Drug Discov. 2014;13:21\u201338.","journal-title":"Nat Rev Drug Discov."},{"key":"964_CR7","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.4049\/jimmunol.167.7.3545","volume":"167","author":"L Dumoutier","year":"2001","unstructured":"Dumoutier L, Leemans C, Lejeune D, Kotenko SV, Renauld JC. Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J Immunol. 2001;167:3545\u20139.","journal-title":"J Immunol."},{"key":"964_CR8","doi-asserted-by":"crossref","first-page":"47517","DOI":"10.1074\/jbc.M205114200","volume":"277","author":"J Parrish-Novak","year":"2002","unstructured":"Parrish-Novak J, Xu W, Brender T, Yao L, Jones C, West J, et al. Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions. J Biol Chem. 2002;277:47517\u201323.","journal-title":"J Biol Chem"},{"key":"964_CR9","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature12873","volume":"506","author":"Y Okada","year":"2014","unstructured":"Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature. 2014;506:376\u201381.","journal-title":"Nature."},{"key":"964_CR10","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365:2205\u201319.","journal-title":"N Engl J Med."},{"key":"964_CR11","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/ar2481","volume":"10","author":"SK Drexler","year":"2008","unstructured":"Drexler SK, Kong PL, Wales J, Foxwell BM. Cell signalling in macrophages, the principal innate immune effector cells of rheumatoid arthritis. Arthritis Res Ther. 2008;10:216.","journal-title":"Arthritis Res Ther."},{"key":"964_CR12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/art.30081","volume":"63","author":"J Sokolove","year":"2011","unstructured":"Sokolove J, Zhao X, Chandra PE, Robinson WH. Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fc\u03b3 receptor. Arthritis Rheum. 2011;63:53\u201362.","journal-title":"Arthritis Rheum."},{"key":"964_CR13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrrheum.2011.23","volume":"7","author":"JR Edwards","year":"2011","unstructured":"Edwards JR, Mundy GR. Advances in osteoclast biology: old findings and new insights from mouse models. Nat Rev Rheumatol. 2011;7:235\u201343.","journal-title":"Nat Rev Rheumatol."},{"key":"964_CR14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1074-7613(03)00174-2","volume":"19","author":"F Geissmann","year":"2003","unstructured":"Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 2003;19:71\u201382.","journal-title":"Immunity."},{"key":"964_CR15","first-page":"7","volume-title":"Osteoimmunology","author":"DL Galson","year":"2010","unstructured":"Galson DL, Roodman GD. Origins of Osteoclasts. In: Osteoimmunology. San Diego, USA: Academic Press; 2010. p. 7\u201341."},{"key":"964_CR16","doi-asserted-by":"crossref","first-page":"e47930","DOI":"10.1371\/journal.pone.0047930","volume":"7","author":"R Matsubara","year":"2012","unstructured":"Matsubara R, Kukita T, Ichigi Y, Takigawa I, Qu P-F, Funakubo N, et al. Characterization and identification of subpopulations of mononuclear preosteoclasts induced by TNF-\u03b1 in combination with TGF-\u03b2 in rats. PLoS One. 2012;7:e47930.","journal-title":"PLoS One"},{"key":"964_CR17","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/apm.12416","volume":"123","author":"SR Greisen","year":"2015","unstructured":"Greisen SR, Einarsson HB, Hvid M, Hauge E-M, Deleuran B, Kragstrup TW. Spontaneous generation of functional osteoclasts from synovial fluid mononuclear cells as a model of inflammatory osteoclastogenesis. APMIS. 2015;123:779\u201386.","journal-title":"APMIS."},{"key":"964_CR18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/03009740903170823","volume":"39","author":"T Alan\u00e4r\u00e4","year":"2010","unstructured":"Alan\u00e4r\u00e4 T, Karstila K, Moilanen T, Silvennoinen O, Isom\u00e4ki P. Expression of IL-10 family cytokines in rheumatoid arthritis: elevated levels of IL-19 in the joints. Scand J Rheumatol. 2010;39:118\u201326.","journal-title":"Scand J Rheumatol."},{"key":"964_CR19","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/rheumatology\/ken061","volume":"47","author":"N Sakurai","year":"2008","unstructured":"Sakurai N, Kuroiwa T, Ikeuchi H, Hiramatsu N, Maeshima A, Kaneko Y, et al. Expression of IL-19 and its receptors in RA: potential role for synovial hyperplasia formation. Rheumatology (Oxford). 2008;47:815\u201320.","journal-title":"Rheumatology (Oxford)"},{"key":"964_CR20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cyto.2007.10.004","volume":"41","author":"TW Kragstrup","year":"2008","unstructured":"Kragstrup TW, Otkjaer K, Holm C, J\u00f8rgensen A, Hokland M, Iversen L, et al. The expression of IL-20 and IL-24 and their shared receptors are increased in rheumatoid arthritis and spondyloarthropathy. Cytokine. 2008;41:16\u201323.","journal-title":"Cytokine."},{"key":"964_CR21","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1002\/art.22039","volume":"54","author":"Y-H Hsu","year":"2006","unstructured":"Hsu Y-H, Li H-H, Hsieh M-Y, Liu M-F, Huang K-Y, Chin L-S, et al. Function of interleukin-20 as a proinflammatory molecule in rheumatoid and experimental arthritis. Arthritis Rheum. 2006;54:2722\u201333.","journal-title":"Arthritis Rheum."},{"key":"964_CR22","doi-asserted-by":"crossref","first-page":"R200","DOI":"10.1186\/ar4038","volume":"14","author":"MC Lebre","year":"2012","unstructured":"Lebre MC, Jonckheere CL, Kraan MC, van Kuijk AW, Bos JD, de Rie M, et al. Expression of IL-20 in synovium and lesional skin of patients with psoriatic arthritis: differential response to alefacept treatment. Arthritis Res Ther. 2012;14:R200.","journal-title":"Arthritis Res Ther."},{"key":"964_CR23","doi-asserted-by":"crossref","first-page":"e47673","DOI":"10.1371\/journal.pone.0047673","volume":"7","author":"E Omoyinmi","year":"2012","unstructured":"Omoyinmi E, Forabosco P, Hamaoui R, Bryant A, Hinks A, Ursu S, et al. Association of the IL-10 gene family locus on chromosome 1 with juvenile idiopathic arthritis (JIA). PLoS One. 2012;7:e47673.","journal-title":"PLoS One"},{"key":"964_CR24","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/cei.12449","volume":"179","author":"R Scrivo","year":"2015","unstructured":"Scrivo R, Conigliaro P, Riccieri V, Di Franco M, Alessandri C, Spadaro A, et al. Distribution of interleukin-10 family cytokines in serum and synovial fluid of patients with inflammatory arthritis reveals different contribution to systemic and joint inflammation. Clin Exp Immunol. 2015;179:300\u20138.","journal-title":"Clin Exp Immunol."},{"key":"964_CR25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/cei.12577","volume":"180","author":"TW Kragstrup","year":"2015","unstructured":"Kragstrup TW, Andersen T, Holm C, Schi\u00f8ttz-Christensen B, Jurik AG, Hvid M, et al. Toll-like receptor 2 and 4 induced interleukin-19 dampens immune reactions and associates inversely with spondyloarthritis disease activity. Clin Exp Immunol. 2015;180:233\u201342.","journal-title":"Clin Exp Immunol."},{"key":"964_CR26","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1084\/jem.20102234","volume":"208","author":"Y-H Hsu","year":"2011","unstructured":"Hsu Y-H, Chen W-Y, Chan C-H, Wu C-H, Sun Z-J, Chang M-S. Anti-IL-20 monoclonal antibody inhibits the differentiation of osteoclasts and protects against osteoporotic bone loss. J Exp Med. 2011;208:1849\u201361.","journal-title":"J Exp Med."},{"key":"964_CR27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.2041-1014.2010.00576.x","volume":"25","author":"Y Li","year":"2010","unstructured":"Li Y, Messina C, Bendaoud M, Fine DH, Schreiner H, Tsiagbe VK. Adaptive immune response in osteoclastic bone resorption induced by orally administered Aggregatibacter actinomycetemcomitans in a rat model of periodontal disease. Mol Oral Microbiol. 2010;25:275\u201392.","journal-title":"Mol Oral Microbiol."},{"key":"964_CR28","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/art.39083","volume":"67","author":"L \u0160enolt","year":"2015","unstructured":"\u0160enolt L, Leszczynski P, Dokoupilov\u00e1 E, G\u00f6thberg M, Valencia X, Hansen BB, et al. Efficacy and safety of anti-interleukin-20 monoclonal antibody in patients with rheumatoid arthritis: a randomized phase IIa trial. Arthritis Rheum. 2015;67:1438\u201348.","journal-title":"Arthritis Rheum."},{"key":"964_CR29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","volume":"21","author":"K Wolk","year":"2004","unstructured":"Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K. IL-22 increases the innate immunity of tissues. Immunity. 2004;21:241\u201354.","journal-title":"Immunity."},{"key":"964_CR30","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/annrheumdis-2012-202735","volume":"73","author":"K H\u00f8rslev-Petersen","year":"2014","unstructured":"H\u00f8rslev-Petersen K, Hetland ML, Junker P, P\u00f8denphant J, Ellingsen T, Ahlquist P, et al. Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial. Ann Rheum Dis. 2014;73:654\u201361.","journal-title":"Ann Rheum Dis"},{"key":"964_CR31","doi-asserted-by":"crossref","unstructured":"H\u00f8rslev-Petersen K, Hetland ML, \u00d8rnbjerg LM, Junker P, P\u00f8denphant J, Ellingsen T, Ahlquist P, Lindegaard H, Linauskas A, Schlemmer A, Dam MY, Hansen I, Lottenburger T, Ammitzb\u00f8ll CG, J\u00f8rgensen A, Krintel SB, Raun J, Johansen JS, \u00d8stergaard M, Stengaard-Pedersen K, OPERA study-group. Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction: a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA). Ann Rheum Dis. 2015. doi: 10.1136\/annrheumdis-2015-208166 .","DOI":"10.1136\/annrheumdis-2015-208166"},{"key":"964_CR32","first-page":"743","volume":"26","author":"D Heijde van der","year":"1999","unstructured":"van der Heijde D. How to read radiographs according to the Sharp\/van der Heijde method. J Rheumatol. 1999;26:743\u20135.","journal-title":"J Rheumatol."},{"key":"964_CR33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/2193-1801-2-263","volume":"2","author":"TW Kragstrup","year":"2013","unstructured":"Kragstrup TW, Vorup-Jensen T, Deleuran B, Hvid M. A simple set of validation steps identifies and removes false results in a sandwich enzyme-linked immunosorbent assay caused by anti-animal IgG antibodies in plasma from arthritis patients. Springerplus. 2013;2:263.","journal-title":"Springerplus."},{"key":"964_CR34","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/art.10871","volume":"48","author":"AB Blom","year":"2003","unstructured":"Blom AB, Radstake TRDJ, Holthuysen AEM, Sl\u00f6etjes AW, Pesman GJ, Sweep FGJ, et al. Increased expression of Fcgamma receptors II and III on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor alpha and matrix metalloproteinase. Arthritis Rheum. 2003;48:1002\u201314.","journal-title":"Arthritis Rheum."},{"key":"964_CR35","doi-asserted-by":"crossref","first-page":"R42","DOI":"10.1186\/ar4471","volume":"16","author":"TW Kragstrup","year":"2014","unstructured":"Kragstrup TW, Jalilian B, Hvid M, Kj\u00e6rgaard A, \u00d8stg\u00e5rd R, Schi\u00f8ttz Christensen B, et al. Decreased plasma levels of soluble CD18 link leukocyte infiltration with disease activity in spondyloarthritis. Arthritis Res Ther. 2014;16:R42.","journal-title":"Arthritis Res Ther."},{"key":"964_CR36","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/ard.42.6.605","volume":"42","author":"TM Burns","year":"1983","unstructured":"Burns TM, Calin A. The hand radiograph as a diagnostic discriminant between seropositive and seronegative \u201crheumatoid arthritis\u201d: a controlled study. Ann Rheum Dis. 1983;42:605\u201312.","journal-title":"Ann Rheum Dis."},{"key":"964_CR37","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6","volume":"43","author":"EJ Kroot","year":"2000","unstructured":"Kroot EJ, de Jong BA, van Leeuwen MA, Swinkels H, van den Hoogen FH, van't Hof M, et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 2000;43:1831\u20135.","journal-title":"Arthritis Rheum."},{"key":"964_CR38","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrrheum.2012.153","volume":"8","author":"G Schett","year":"2012","unstructured":"Schett G, Gravallese E. Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment. Nat Rev Rheumatol. 2012;8:656\u201364.","journal-title":"Nat Rev Rheumatol."},{"key":"964_CR39","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1002\/art.30469","volume":"63","author":"RJ Marijnissen","year":"2011","unstructured":"Marijnissen RJ, Koenders MI, Smeets RL, Stappers MHT, Nickerson Nutter C, Joosten LAB, et al. Increased expression of interleukin\u201022 by synovial Th17 cells during late stages of murine experimental arthritis is controlled by interleukin\u20101 and enhances bone degradation. Arthritis Rheum. 2011;63:2939\u201348.","journal-title":"Arthritis Rheum."},{"key":"964_CR40","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1136\/ard.2011.152074","volume":"70","author":"J Leipe","year":"2011","unstructured":"Leipe J, Schramm MA, Grunke M, Baeuerle M, Dechant C, Nigg AP, et al. Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritis. Ann Rheum Dis. 2011;70:1453\u20137.","journal-title":"Ann Rheum Dis."},{"key":"964_CR41","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/art.23417","volume":"58","author":"SB Cohen","year":"2008","unstructured":"Cohen SB, Dore RK, Lane NE, Ory PA, Peterfy CG, Sharp JT, et al. Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial. Arthritis Rheum. 2008;58:1299\u2013309.","journal-title":"Arthritis Rheum."},{"key":"964_CR42","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/ni.2637","volume":"14","author":"IA Myles","year":"2013","unstructured":"Myles IA, Fontecilla NM, Valdez PA, Vithayathil PJ, Naik S, Belkaid Y, et al. Signaling via the IL-20 receptor inhibits cutaneous production of IL-1\u03b2 and IL-17A to promote infection with methicillin-resistant Staphylococcus aureus. Nat Immunol. 2013;14:804\u201311.","journal-title":"Nat Immunol."},{"key":"964_CR43","doi-asserted-by":"crossref","first-page":"e0137474","DOI":"10.1371\/journal.pone.0137474","volume":"10","author":"P Matt","year":"2015","unstructured":"Matt P, Lindqvist U, Kleinau S. Elevated membrane and soluble CD64: a novel marker reflecting altered Fc\u03b3R function and disease in early rheumatoid arthritis that can be regulated by anti-rheumatic treatment. PLoS One. 2015;10:e0137474.","journal-title":"PLoS One"},{"key":"964_CR44","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/annrheumdis-2012-201517","volume":"72","author":"D Aletaha","year":"2013","unstructured":"Aletaha D, Alasti F, Smolen JS. Rheumatoid factor determines structural progression of rheumatoid arthritis dependent and independent of disease activity. Ann Rheum Dis. 2013;72:875\u201380.","journal-title":"Ann Rheum Dis."},{"key":"964_CR45","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI60975","volume":"122","author":"U Harre","year":"2012","unstructured":"Harre U, Georgess D, Bang H, Bozec A, Axmann R, Ossipova E, et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest. 2012;122:1791\u2013802.","journal-title":"J Clin Invest."},{"key":"964_CR46","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev-med-051113-024537","volume":"66","author":"JJ O'Shea","year":"2015","unstructured":"O'Shea JJ, Schwartz DM, Villarino AV, Gadina M, McInnes IB, Laurence A. The JAK-STAT pathway: impact on human disease and therapeutic intervention. Annu Rev Med. 2015;66:311\u201328.","journal-title":"Annu Rev Med."}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-016-0964-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T04:55:36Z","timestamp":1498280136000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.com\/content\/18\/1\/61"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,11]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["964"],"URL":"https:\/\/doi.org\/10.1186\/s13075-016-0964-7","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,11]]},"article-number":"61"}}